A retrospective, multicentre study of perampanel given as monotherapy in routine clinical care in people with epilepsy

Abstract

PURPOSE Perampanel is approved for adjunctive treatment of focal seizures, with or without secondarily generalised seizures, and for primary generalised tonic-clonic seizures in people with epilepsy aged ≥12 years. Perampanel was recently approved for monotherapy use for partial seizures in the United States. This study provides insight into the feasibility… (More)
DOI: 10.1016/j.seizure.2017.10.015

Topics

Statistics

0501002015201620172018
Citations per Year

98 Citations

Semantic Scholar estimates that this publication has 98 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{GilNagel2017ARM, title={A retrospective, multicentre study of perampanel given as monotherapy in routine clinical care in people with epilepsy}, author={Antonio Gil-Nagel and Sergey Burd and M Toledo and J. W. Sander and Anna V. Lebedeva and Anna Patten and Antonio Laurenza}, journal={Seizure}, year={2017}, volume={54}, pages={61-66} }